Miller KD - Search Results

1

Issues and challenges for antiangiogenic therapies.

Miller KD. Miller KD. Breast Cancer Res Treat. 2002 Oct;75 Suppl 1:S45-50; discussion S57-8. doi: 10.1023/a:1020317917759. Breast Cancer Res Treat. 2002. PMID: 12353823 Review.

2

Breast cancer: challenges and opportunities.

Sledge GW Jr, Miller K. Sledge GW Jr, et al. Semin Oncol. 1999 Dec;26(6 Suppl 18):1-5. Semin Oncol. 1999. PMID: 10892573 Review.

3

Redefining the target: chemotherapeutics as antiangiogenics.

Miller KD, Sweeney CJ, Sledge GW Jr. Miller KD, et al. J Clin Oncol. 2001 Feb 15;19(4):1195-206. doi: 10.1200/JCO.2001.19.4.1195. J Clin Oncol. 2001. PMID: 11181686 Review.

4

The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors.

Sweeney CJ, Miller KD, Sissons SE, Nozaki S, Heilman DK, Shen J, Sledge GW Jr. Sweeney CJ, et al. Among authors: miller kd. Cancer Res. 2001 Apr 15;61(8):3369-72. Cancer Res. 2001. PMID: 11309294

5

Angiogenesis and antiangiogenic therapy.

Sledge GW Jr, Miller KD. Sledge GW Jr, et al. Among authors: miller kd. Curr Probl Cancer. 2002 Jan-Feb;26(1):1-60. Curr Probl Cancer. 2002. PMID: 11961506 Review. No abstract available.

6

The Snark is a Boojum: the continuing problem of drug resistance in the antiangiogenic era.

Miller KD, Sweeney CJ, Sledge GW Jr. Miller KD, et al. Ann Oncol. 2003 Jan;14(1):20-8. doi: 10.1093/annonc/mdg033. Ann Oncol. 2003. PMID: 12488288 Free article. Review.

7

Resistance in the anti-angiogenic era: nay-saying or a word of caution?

Sweeney CJ, Miller KD, Sledge GW Jr. Sweeney CJ, et al. Among authors: miller kd. Trends Mol Med. 2003 Jan;9(1):24-9. doi: 10.1016/s1471-4914(02)00007-2. Trends Mol Med. 2003. PMID: 12524207 Review.

8

E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer.

Miller KD. Miller KD. Clin Breast Cancer. 2003 Feb;3(6):421-2. doi: 10.3816/CBC.2003.n.007. Clin Breast Cancer. 2003. PMID: 12636887 No abstract available.

9

Exploiting the hallmarks of cancer: the future conquest of breast cancer.

Sledge GW Jr, Miller KD. Sledge GW Jr, et al. Among authors: miller kd. Eur J Cancer. 2003 Aug;39(12):1668-75. doi: 10.1016/s0959-8049(03)00273-9. Eur J Cancer. 2003. PMID: 12888360 Review.

10

Recent translational research: antiangiogenic therapy for breast cancer - where do we stand?

Miller KD. Miller KD. Breast Cancer Res. 2004;6(3):128-32. doi: 10.1186/bcr782. Epub 2004 Mar 18. Breast Cancer Res. 2004. PMID: 15084233 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

525 results

Search Page

Filters